Portfolio of Gene Editing (CRISPR) Stocks
Here are 4 gene editing stocks that use CRISPR technology.
| 4 Portfolio of Gene Editing (CRISPR) Stocks | ||
|---|---|---|
Stock Returns & Price Chart | Symbol | Recent Prices & |
| Crispr Therapeutics | CRSP | |
| Editas Medicine | EDIT | |
| Intellia Therapeutics | NTLA | |
| Vertex Pharmaceuticals | VRTX | |
| Price data from Quandl as of most recent close. | ||
| 4 Portfolio of Gene Editing (CRISPR) Stocks | ||
|---|---|---|
Stock Returns & Price Chart | Symbol | Recent Dividends |
| Crispr Therapeutics | CRSP | |
| Editas Medicine | EDIT | |
| Intellia Therapeutics | NTLA | |
| Vertex Pharmaceuticals | VRTX | |
| Dividend chart data from Quandl as of today. | ||
To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.All 4 stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.
The current value of a $10,000 investment is $14,858. The percent return is 48.58%. The annualized return is 21.89%.
| Return Summary for Portfolio of Gene Editing (CRISPR) Stocks | |
|---|---|
| Start Date | Nov-30-2017 |
| Start Investment | $10,000.00 |
| End Date | Nov-18-2019 |
| Current Value of Investment | $14,858.32 |
| Total Return | 48.58% |
| Annualized Return | 21.89% |
| Min Date | Nov-30-2017 |
| Min Price | $10,000.00 |
| Max Date | May-31-2018 |
| Max Price | $18,066.88 |
| # Values | 25 |
| Number Returns | 300 |
| Number Profitable Returns | 140 |
| Percent Profitable Returns | 46.67% |
| Number Unprofitable Returns | 160 |
| Percent Unprofitable Returns | 53.33% |
| Profitable to Unprofitable Returns Ratio | 0.88 |
NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.